Nancy E. Kemeny
Memorial Sloan-Kettering Cancer Center
Weill Medical College
USA
Name/email consistency: high
- Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. Kemeny, N.E., Jarnagin, W.R., Capanu, M., Fong, Y., Gewirtz, A.N., Dematteo, R.P., D'Angelica, M.I. J. Clin. Oncol. (2011)
- The management of resectable and unresectable liver metastases from colorectal cancer. Kemeny, N. Curr. Opin. Oncol (2010)
- Implanted hepatic arterial infusion pumps. Callahan, M.K., Kemeny, N.E. Cancer. J (2010)
- Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Kemeny, N., Capanu, M., D'Angelica, M., Jarnagin, W., Haviland, D., Dematteo, R., Fong, Y. Ann. Oncol. (2009)
- Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. Kemeny, N.E., Melendez, F.D., Capanu, M., Paty, P.B., Fong, Y., Schwartz, L.H., Jarnagin, W.R., Patel, D., D'Angelica, M. J. Clin. Oncol. (2009)
- Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Kemeny, N.E., Niedzwiecki, D., Hollis, D.R., Lenz, H.J., Warren, R.S., Naughton, M.J., Weeks, J.C., Sigurdson, E.R., Herndon, J.E., Zhang, C., Mayer, R.J. J. Clin. Oncol. (2006)
- Management of liver metastases from colorectal cancer. Kemeny, N. Oncology (Williston Park, N.Y.) (2006)
- Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Kemeny, N., Jarnagin, W., Paty, P., Gönen, M., Schwartz, L., Morse, M., Leonard, G., D'Angelica, M., DeMatteo, R., Blumgart, L., Fong, Y. J. Clin. Oncol. (2005)
- Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Kemeny, N., Eid, A., Stockman, J., Gonen, M., Schwartz, L., Tetzlaff, E., Paty, P. J. Surg. Oncol (2005)
- Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Kemeny, N., Garay, C.A., Gurtler, J., Hochster, H., Kennedy, P., Benson, A., Brandt, D.S., Polikoff, J., Wertheim, M., Shumaker, G., Hallman, D., Burger, B., Gupta, S. J. Clin. Oncol. (2004)
- Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer. Kemeny, N., Tong, W., Gonen, M., Stockman, J., Di Lauro, C., Teitcher, J., White, P., Price, C., Saltz, L., Sharma, S., Graham, M.A. Ann. Oncol. (2002)
- Hepatic-arterial chemotherapy. Kemeny, N., Fata, F. Lancet Oncol. (2001)
